INTRODUCTION
Human polymorphonuclear neutrophils (PMN) are a major class of the non-specific immune response against infections. This is due, in part, to their ability to produce toxic forms of reactive oxygen species (ROS) . Recent work has shown that glutamine supplementation in vitro enhances both phagocytosis and ROS in isolated PMN (3) and, in vivo, suppresses IL-8 production by PMN (4) . This has important consequences, as glutamine appears to exert a regulatory influence on inflammatory processes by PMN responding to inflammatory and infectious stimuli. For example, PMN taken from patients with burns (5) or after surgery (6) have been shown to have improved bactericidal activity in vitro when glutamine is added to the culture medium for incubation.
Glutamine is an important substrate for some key cells of the immune system such as macrophages and lymphocytes (7, 8) . It acts as a nitrogen donor for purine and pyrimidine nucleotide synthesis for new DNA synthesis and for mRNA repair.
Although classified as non-essential, recent evidence suggests that glutamine is conditionally essential when it becomes rapidly depleted in the blood in stressful situations. Plasma glutamine concentrations are substantially decreased by clinical trauma such as major surgery by 37% (9) , or after prolonged, exhaustive exercise by 20-25% (10) . The provision of glutamine or glutamine precursors to endurance by guest on April 10, 2017 http://www.jbc.org/ Downloaded from athletes has resulted in a decreased self-reported incidence of illness, particularly upper respiratory tract infections (URTI), in four studies (see Castell 2003, (4) ).
Increasing evidence, in vitro and in vivo suggests that PMN may benefit from exogenous glutamine which repletes the decrease in the blood concentration observed after stress.
The energy substrate for PMN has traditionally been thought to be glucose.
However, it is possible that PMN could use glutamine, in particular in cases such as severe infection where glucose is restricted. Evidence for a direct effect of glutamine on neutrophil function has been demonstrated in rats where it was shown that isolated PMN utilized glutamine at a rate of 12.8 nmol min¯¹mg protein¯¹ (11) in the absence of glucose. The same workers further confirmed the presence of phosphate-dependent glutaminase (GA) in rat PMN using Western blots and immunocytochemistry methods. To date, the presence of GA in human PMN has not been demonstrated, despite several attempts to do so.
Strenuous exercise stimulates leukocytosis and neutrophilia (12) (13) (14) , and the release of immature PMN from bone marrow (15, 16) . However, there are conflicting reports upon the effects of exercise on ROS release by PMN (17). Significant increases have been observed in the plasma concentration of IL-8 (approximately 2-fold) immediately after and 1.5h after a marathon (18) , and in cell IL-8 production after a rowing ergotest (19) . This suggests enhanced post-exercise activation of PMN.
Significant decreases in post-exercise neutrophilia (approximately 1.75-fold) and in cell IL-8 production (approximately 3.5-fold) have been observed after a marathon in runners taking glutamine compared with placebo (20). Since then, in three further studies in our laboratory, a reduction in IL-8 associated with glutamine feeding after exercise has been observed (see Castell, 2003, (4) ). Clinical studies (21, 22) established that IL-8 production was reduced in both surgical patients and patients with acute pancreatitis who received glutamine enriched parenteral nutrition. IL-8 is a potent chemoattractant that perpetuates the inflammatory response and attracts PMN to the site of tissue damage.
The present study was set up to establish (1) whether glutamine supplementation affects human neutrophil respiratory burst via in vitro incubation of blood with/without glutamine, and (2) if human PMN utilize glutamine, via the presence of GA, using both immunochemical techniques and confocal microscopy.
MATERIALS AND METHODS
Subjects and Blood Samples -Ethical permission for the studies was obtained from the Central Oxford Research Ethics Committee (COREC). Resting blood samples were taken from healthy controls recruited from among colleagues.
Neutrophil function was measured with a novel chemiluminescence assay as described below.
Isolation of PMN -Isolated whole cells and subcellular neutrophil fractions
were assayed for the presence of glutaminase. Neutrophils were isolated as previously described (23) . Briefly, 5 ml of anticoagulated (potassium EDTA 1.5 mg/ml) blood was layered on top of 4 ml of PolymorphPrep™ (Nycomed Pharma AS) in a 15 ml conical tube that was then spun at 1000xg for 45 minutes. and supernatants were then subjected to isopycnic sucrose density gradient fractionation on linear 20-55% sucrose gradients in a Beckman SW-28 swinging bucket rotor (100,000 × g; 3 h, 4 °C) exactly as previously described. 1.5-ml fractions were collected from each gradient and analyzed for marker proteins, plasma membrane (alkaline phosphatase), primary granules (myeloperoxidase), and secondary granules (lactoferrin) as previously described (25) . E.coli as a glutathione S-transferase (GST) fusion protein (GST-GA 347-602 ). Protein expression and affinity purification were done as previously described (26) using a glutathione-Sepharose affinity column. The purified recombinant protein was used for hyperimmunization of New Zealand White rabbits and polyclonal antibodies were generated as described elsewhere (27) .
Whole Blood Neutrophil

SDS-PAGE and Western Blot of Glutaminase -Approximately 40 µg of
neutrophil membrane sub-fractions, prepared by nitrogen cavitation as previously described (25) were suspended in sample buffer (62 mmol/L TRIS-Cl, pH6.8, 2%
SDS, 10% glycerol, and 0.01% bromophenol blue with 5% 2-mercaptoethanol) and incubated for 5 min at 100ºC and then applied to lanes of a 12% polyacrylamide mini gel: electrophoresis was performed in TRIS-buffered saline (TBS) at a constant current of 60 mA for two hours. Molecular weight standards (Biorad) were run simultaneously. The gel was stained with Coomassie Blue and dried. A parallel SDS-PAGE gel was run as above, and the separated proteins were transferred directly by semi-dry blotting onto polyvinyl difluoride (PVDF) transfer membrane for 90 min at a constant current of 0.8 mA. After saturation of the non-specific sites with 5% nonfat milk-TBS overnight, the proteins were probed with a 1:200 dilution of rabbit anti-human glutaminase antibody prepared as described below. The blot was then washed in 20 mM TRIS-HCl, pH 7.5, 0.14 mM NaCl containing 0.4% Tween-20
(TBS-Tween) and then incubated for an hour in an anti-rabbit peroxidase conjugate
IgG antibody diluted 1:1000 in TBS-Tween, the immunoblot was exposed to enhanced chemiluminescence (ECL) immunoassay substrate reagent (Amersham Pharmaceuticals, UK) for 1 minute to detect any signal, and then the membrane was exposed to x-ray film for 5 min. Statistical Analysis -Results were compared using non-parametric analysis with Wilcoxon paired t-tests.
RESULTS
Real-Time Oxidative Response of Stimulated Leukocytes in the Presence of
Glutamine -whole blood leukocytes from healthy control individuals stimulated with PMA (final concentration 0.16 µM) and fMLP (final concentration 1µM) were incubated with the highly sensitive real-time chemiluminescence probe Pholasin to examine reactive oxygen species (ROS) release in the presence and absence of glutamine. Four out of six samples gave an increased response (39.2%) to fMLP when incubated with glutamine compared with no glutamine. In the fMLP experiments there were two individuals who did not respond to the addition of glutamine. However, the response was not diminished whether or not glutamine was present. In a separate group, four out of four samples gave an increased response to PMA (31.1%) (Fig 1) .
Glutamine stimulated the oxidative burst from PMA-stimulated cells approximately two-fold without affecting the speed of response (Fig 1a) . However, fMLP-stimulated cells (Fig. 1b) increased both the speed of response and the oxidative burst in the presence of glutamine. (Fig 2b) . In contrast fMLP had very little effect on surface GA levels in the two populations M1 and M2 (Fig 2c) . Imaging the surface of PMN in 0.5 micron sections labeled with FITC-anti-GA (Fig 3) showed that the GA was on, or near the cell surface and could be detected 3-3.5 microns into the cell surface, but most intensely at the surface of the cell.
Detection of Glutaminase on the
Secretion of Glutaminase -A number of human cells, including liver and
kidney have been reported to produce GA, but to date GA has not been identified in human PMN. In order to investigate if the source of the GA came from the PMN themselves, we stimulated the cells with PMA (100 ng/ml) and fMLP for 30 min. The PBS in which 5 x 10 6 cells had been incubated were collected and concentrated to 100 µl volumes. Then 50 µl aliquots of these were loaded on a 12% v/v SDS-PAGE gel, together with purified GA, and immunoblotted onto PVDF membranes and probed with rabbit anti-human glutaminase polyclonal antisera. As shown in Figure 2d , Western blot analysis revealed that the cell free supernatants from cells that had been treated with phorbol ester contained GA. In contrast, supernatants from resting cells and fMLP treated cells contained no GA as detected by immunoblotting. The presence of GA in the cell media suggested it might be secreted from the cells. Thus it was next decided to examine neutrophil subfractions, which had been previously prepared by nitrogen cavitation into four main fractions, namely primary granules (α), secondary granules (β), endoplasmic and plasma membrane enriched fraction (γ) and cell supernatant (S). The protein profiles of these four fractions are shown in Fig 4a and the immunoblot of these protein fractions (Fig 4b) reveal that a protein 65-70 kDa was detected in the secondary granules, but not in any of the other purified subcellular fraction.
DISCUSSION
The fact that lymphocytes and macrophages use high rates of glutamine has been known for a number of years (7, 8) . More recent observations have provided evidence that glutamine is also utilized by rat PMN (28) . The ability of glutamine metabolism to enhance the bacterial function of PMN has been investigated in burns patients (5) Moreover, blocking glutamine metabolism by inhibiting GA in PMN causes a significant decrease in superoxide production. Therefore, the presence and subcellular location of glutamine appears to be important for glutamine dependent superoxide production by PMN.
In the present study, the results obtained support the notion that glutamine can enhance oxidative burst by human PMN in the presence of phorbol esters and formyl tripeptide stimulants. These data were achieved using a real-time in vitro assay of oxidative burst. The supplementation of whole blood leukocytes with 2mM
glutamine not only led to a greater production of superoxide but also increased the initial rate of activation. GA activity has been reported in rat PMN (28) and numerous studies have detected GA in human tumor cells (30, 31) where GA is an essential requirement for cell growth.
In vitro data, from oxidative burst measurement in culture medium with/without glutamine used to incubate whole blood samples from the marathon runners, suggested a role for glutamine and glutaminase in neutrophil metabolism during inflammation. However, during inflammation, phagosomes only fuse with the extracellular matrix at the cytosolic and membrane components, and the NADPH oxidase pathway translocates to form the complex upon alteration. Therefore, if glutamine plays a role in O 2 -production, one might expect to find GA in a similar location. The present results indicate that GA is present on the surface of cells and is released into the medium upon PMA, but not fMLP, stimulation. In the present investigation more precise information was obtained on the localization of GA employing confocal microscopy. By generating 0.5uM optical sections through individual PMN it was observed that GA was distributed 0-3.5 µM into the cell surface. PMN are ruffled cells and the GA appeared to be predominantly localized in pseudo lamellipodia at, or near, the plasma membrane.
In an initial study, little or no evidence of the presence of GA in human PMN was found using three different methods: freeze-thaw, homogenization and nebulization. None of these techniques was apparently able to break open the granules. Consequently, in order to determine in more detail the subcellular source of glutamine in human PMN, other techniques were employed. Nitrogen cavitation and discontinuous Percoll density gradient centrifugation provided a simple and rapid means of separating azurophil granules (α) specific granules (β) and plasma membrane (γ) vesicles as well as a cytoplasm fraction. GA was detected in the secondary granules but, surprisingly, not in the plasma membrane fractions. Our data suggest that, in intact PMN, GA is secreted from the secondary granules and binds to the cell surface. Following PMA but not fMLP stimulation, the GA is removed from the membrane fractions and can be found in the extracellular culture medium. It seems that, as granules fuse with the plasma membrane at the sites of developing phagosomes, the NADPH oxidase and GA enzymes would be in close proximity to the plasma membrane in response to stimulation. This would bring them into close contact with their target substrates. Interestingly, a number of groups have recently identified isoforms of glutaminase in human tumor cell lines at the mRNA and protein level (31) , and in mammalian brain cells (32) . In the present study, treatment of human PMN with PMA, a degranulating agent, resulted in the release of glutaminase from the cell surface into cell culture media. However, three bands were recognized by the polyclonal anti-glutaminase antibody. This is consistent with the results of previous investigators revealing limited proteolytic digestion of isoforms of GA (33) .
When intact secondary granules were subsequently examined by Western blotting, a single non-proteolytic glutaminase band of approximately 65 kDa was observed and compared favorably with that found for rat neutrophil GA, which is around 65 kDa In conclusion, the present study suggests that glutamine supplementation might enhance the respiratory burst of human PMN to specific inflammatory stimuli in vitro. Moreover, the novel finding has been made that there is a sub-cellular source of GA, the major enzyme responsible for glutamine metabolism, in the secretory granules of human PMN. This is likely to contribute to the modulation of immune function of PMN in clinical and exercise-induced stress. 
